ALNYLAM PHARMACEUTICALS, INC.·4

May 22, 4:18 PM ET

SCHULMAN AMY W 4

4 · ALNYLAM PHARMACEUTICALS, INC. · Filed May 22, 2026

Research Summary

AI-generated summary of this filing

Updated

Alnylam (ALNY) Director Amy W. Schulman Receives RSU and Option Award

What Happened

  • Amy W. Schulman, a director of Alnylam Pharmaceuticals (ALNY), was granted awards on 2026-05-20: 838 restricted stock units (RSUs) and a derivative award covering 1,802 shares. Both grants show $0 acquisition price (i.e., compensation awards), totaling 2,640 shares on paper and $0 cash paid.
  • These are awards (compensation), not open-market purchases or sales.

Key Details

  • Transaction date: 2026-05-20; Filing date: 2026-05-22 (filed timely under the Form 4 two-business-day rule).
  • Price: $0.00 per share — these are compensation grants, not cash purchases.
  • Shares owned after transaction: Not specified in the provided filing details.
  • Footnotes / vesting notes:
    • The 838 shares are RSUs; each RSU converts to one share. RSUs vest in full on the earlier of the first anniversary of the grant or earlier retirement/resignation, provided such retirement/resignation occurs no more than 90 days before the first anniversary.
    • The 1,802-share derivative award is subject to a similar vesting condition (it will vest in full on the earlier of the first anniversary of the grant or certain earlier retirement/resignation timing).

Context

  • Grants like RSUs or option awards are standard director compensation and do not necessarily indicate buying or selling sentiment. They generally vest over time or upon specified conditions; they are not immediate cash purchases or sales.
  • The derivative award should be understood as a future right to obtain shares (subject to vesting), not an immediate share transfer.

Insider Transaction Report

Form 4
Period: 2026-05-20
Transactions
  • Award

    Common Stock

    [F1]
    2026-05-20+83824,049 total
  • Award

    Stock Option (Right to Buy)

    [F2]
    2026-05-20+1,8021,802 total
    Exercise: $298.48From: 2027-05-20Exp: 2036-05-20Common Stock (1,802 underlying)
Footnotes (2)
  • [F1]These shares are represented by restricted stock units (RSUs) granted under the Second Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.
  • [F2]The stock option will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.
Signature
/s/ Brett Budzinski, attorney-in-fact for Amy W. Schulman|2026-05-22

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT